Improving active surveillance for new low-risk prostate cancer
Planning to implement high-quality active surveillance in new-onset favorable risk prostate cancer
['FUNDING_OTHER'] · UNIVERSITY OF MISSOURI-COLUMBIA · NIH-11192834
This project plans ways to make active surveillance safer and more reliable for men newly diagnosed with low-risk prostate cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSOURI-COLUMBIA (nih funded) |
| Locations | 1 site (COLUMBIA, UNITED STATES) |
| Trial ID | NIH-11192834 on ClinicalTrials.gov |
What this research studies
You would be part of efforts with urologists in a statewide quality network to plan better monitoring for new low-risk prostate cancer. The team will push for timely confirmatory testing (MRI or repeat biopsy within six months) and consistent follow-up to detect cancers that become more aggressive. They will use data from the Michigan Urological Surgery Improvement Collaborative and work with clinics to design workflows, provider training, and measurement plans. The goal is a practical implementation plan clinics can adopt to improve safety and consistency of surveillance.
Who could benefit from this research
Good fit: Men newly diagnosed with favorable-risk (low-risk) prostate cancer who are considering or already on active surveillance are the ideal candidates for the resulting implementation efforts.
Not a fit: Men with intermediate- or high-risk prostate cancer, those who have already had definitive treatment, or people treated outside participating clinics are unlikely to benefit from this project.
Why it matters
Potential benefit: If successful, this could help more men avoid unnecessary treatment while making it more likely that progressing cancers are found and treated early.
How similar studies have performed: Evidence supports that confirmatory MRI/biopsy and quality-improvement collaboratives can improve surveillance safety, but consistent statewide implementation has not been widely achieved.
Where this research is happening
COLUMBIA, UNITED STATES
- UNIVERSITY OF MISSOURI-COLUMBIA — COLUMBIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SALES, ANNE EVELYN — UNIVERSITY OF MISSOURI-COLUMBIA
- Study coordinator: SALES, ANNE EVELYN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Chronic Disease, Disease